Stay up to date with respiratory news & updates by subscribing to receive the free RPM print publications or e‑Newsletters.
Gauging your medical group’s success in the “new normal” begins by recognizing what the pre–COVID-19 world looked like for healthcare, according to Cindy Nyberg, Chief Financial Officer and Strategic Planning Consultant, Fulcrum Strategies, Raleigh, NC.
Unemployment hovered around 3.5% and wage growth was somewhere around 3.9% to 4%, and the labor participation rate stood at 63.4% in February 2020. “It seems like it was a million years ago,” Ms Nyberg said. “COVID immediately became a perfect financial storm.”
Quickly, doctors and administrators “experienced something we’ve never, ever experienced before: empty schedules,” she added. The drops in visits and productivity meant pivoting to cashflow modeling to ensure practices could stay open, as well as furloughing staff, seeking out federal aid, and following new safety protocols to protect patients and staff.
Heading into 2021, Ms Nyberg said it is questionable to even suggest healthcare providers are in a “post-COVID world” yet, especially with spikes in infections and deaths across the country.
For business performance, the key to assessing your post–COVID-19 financial reality is to track against pre-pandemic levels, such as your February 2020 performance. Ms Nyberg recommends tracking year-to-date production variances (Figure) in terms of both visits and total revenues to get a better sense of how your recovery is going.
In one practice she works with, the doctors noticed that revenues were up despite visits trending down. One of the reasons why revenues rose was a clean-up effort on aging collection accounts and providers catching up on charts that needed to be closed for claim submittal.
Although that scenario is good for the bottom line, Ms Nyberg noted that having lower visit volumes means their recovery is flat as you look forward to new revenue. “We expected a big return,” she said, but the complications of the pandemic have slowed that effort.
Ms Nyberg points to 5 primary financial challenges that started or evolved in 2020 that will be around for medical groups even as the pandemic winds down.
Payer Mix Changes Due to Unemployment
No matter what happens under the new administration in the White House in terms of further expansion of Affordable Care Act markets and/or Medicaid, there are likely to still be significantly higher numbers of patients who will shift onto Medicaid or exchange plans due to job losses. “For a lot of patients moving into the exchange plans, those exchange plans have higher deductibles and coinsurance,” she said.
To prepare for those effects, Ms Nyberg suggests asking yourself these questions:
Changes in Payer Reimbursement Strategies
The shift toward value-based payment has seen many primary care practices move into accountable care organizations (ACOs) or clinically integrated networks (CINs) to participate in shared savings arrangements. The next step, Ms Nyberg said, is those ACOs reaching out to cost-conscious specialists to participate, since many of the cost drivers for primary care are specialists. Specialists are also moving toward forming their own CINs, which will shift projections of their financial recovery as revenue changes.
One interesting model she has seen comes from Blue Cross Blue Shield (BCBS) of North Carolina, which promotes an “Accelerate to Value” program to encourage practices to join an ACO and move toward capitation. The BCBS program would keep payments at 2019 levels through 2021, but on the contingency that the practices remain independent, join an ACO by the end of 2020, and consider a capitation agreement effective January 1, 2022.
Patient Consumerism
While price transparency has been a major focus for hospital services, Ms Nyberg said practice leaders should think ahead for a similar requirement to extend into ambulatory care in the future.
A good first step is paying close attention to provider quality ratings from payers. In one instance, she worked with a specialized pediatric provider that billed many Level 4 codes, which resulted in a poor cost rating from a payer. The practice and Ms Nyberg had to go back to the managed care company to explain the higher rate of Level 4 codes to update the cost rating.
Telehealth
Virtual visits have been a lifeline for countless practices and patients, but the biggest question on telehealth, Ms Nyberg asserted, is what reimbursement rates will look like after the public health emergency (PHE) ends and some of the emergency regulatory changes end with it. A significant decrease in payments for virtual visits may motivate more practices to push for as many in-person visits as possible, regardless of patient and provider sentiment regarding telemedicine.
Article republished with permission. © 2020 MGMA. For more, visit.mgma.com.